Not logged in, please login to view portfolio!

Registration Open


CPHL Share Price | Citi Pharma Ltd.

CPHL Share Price History

CPHL (Citi Pharma Ltd.) listed in PSX,ACI,ALLSHR,KMIALLSHR. CPHL share price / stock price today is 28.90 PKR. Today volume traded in CPHL is 67.77 K, price change is 0.84%, high price is 29.20 PKR, and low price is 28.75 PKR.

CPHL Performance
Return (%) Absolute Return
1 Week 1 Month 3 Month 6 Month 1 Year
Return -0.72% -6.77% 22.1% 21.17% 33.55%

Company Snapshot

loading
CPHL
2024-06-20 10:36:38
Current
28.90
Change
0.24
Change %
0.84%
Volume
67766.00
Price to Earnings Ratio
0.00
Earning per Share
0.00
Book Value
0.00
Price to Book
0.00
Market Cap
6.6 B
Dividend
0.00
Dividend Yield (%)
0.00 %
Debt to Equity
0.00
Net Profit Margin
0.00 %
Gross Profit Margin
0.00 %
Current Ratio
0.00
Face Value
10.00
Shares
228.46 M
FreeFloat
79.96 M
Free Float %
35.00
Equity to Asset(%)
0.00
Interest
0.00
Beta
1.1569
Upper/Lower Cap
31.10 / 26.22
Times-Revenue Method New
52 Week High
33.85
52 Week Low
19.07
High
29.20
Low
28.75
Previous
28.66
Company Financials
Company Announcements
Date Announce Title Attachments
2024-05-15 Material Information View PDF
2024-05-07 Change of Company Secretary View
2024-05-07 Material Information View PDF
2024-04-30 Transmission of Quarterly Report for the period ended View PDF
2024-04-26 Financial Results for the quarter ended View PDF
2024-04-25 Board Meeting in Progress View
2024-04-18 Board Meeting View
2024-03-04 Transmission of Quarterly Report for Period Ended View PDF
2024-02-29 Financial Results for the Quarter Ended 2023-12-31 View PDF
2024-02-21 Board Meeting View
2023-11-13 Dispatch of Final Dividend Warrants View PDF
2023-11-08 Material Information View PDF
2023-10-31 Transmission of Quarterly Report for the Period Ended September 30, 2023 View PDF
2023-10-30 Financial Results for the Quarter Ended September 30, 2023 View PDF
2023-10-20 Board Meeting View
2023-10-06 Transmission of Annual Report for the year ended 30-06-2023 View PDF
2023-10-06 Notice of Annual General Meeting View PDF
2023-09-28 Financial Results for the year ended 30-06-2023 View PDF
2023-09-21 Board Meeting View
2023-09-21 Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View
2023-09-21 Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View
2023-05-29 Results of Board Meeting 26-05-2023 View PDF
2023-05-26 Emergent Board Meeting in Progress View
2023-05-25 Board Meeting View
2023-04-28 Transmission of Quarterly Report for the Period ended March 31, 2023 View PDF
2023-04-28 Financial Results for the 3rd Quarter ended March 31, 2023 View PDF
2023-04-28 Half Yearly Progress Report for the Period ended December 31, 2022 View PDF
2023-04-28 Annual Progress Report for the Period ended June 30, 2022 View PDF
2023-04-28 Half Yearly Progress Report for the period ended December 31, 2021 View PDF
2023-04-20 Board Meeting View
2023-03-01 Transmission of Half Yearly Report for the period ended December 31, 2022 View PDF
2023-02-28 Financial Results for the 2nd Quarter Ended December 31, 2022 View PDF
2023-02-27 Board Meeting in Progress View
2023-02-20 Board Meeting View
2023-01-02 Corporate Briefing Session View PDF
2022-11-11 Resolutions adopted in Annual General Meeting View PDF
2022-10-31 Transmission of Quarterly Report for the Period Ended September 30, 2022 View PDF
2022-10-28 Change of Management View PDF
2022-10-28 Appointment of Chairman & CEO View PDF
2022-10-28 Financial Results for the Quarter ended September 30, 2022 View PDF
2022-10-21 Notice of Election of Directors under section 159(4) of Companies Act, 2017 View PDF
2022-10-21 Board Meeting View
2022-10-07 Transmission of Annual Report for the year ended June 30, 2022 View PDF
2022-10-07 Notice of Annual General Meeting View PDF
2022-09-23 Financial Results for the year ended June 30, 2022 View PDF
2022-09-16 Board Meeting View
2022-04-28 Transmission of Quarterly Report for the Period Ended March 31, 2022 View PDF
2022-04-12 Board Meeting View
2022-02-28 Transmission of 2nd Quarter Report for the Period ended December 31, 2021 View PDF
2022-02-22 Material Information View PDF
2022-02-22 Financial Results for the 2nd Quarter ended December 31, 2021 View PDF
2022-02-18 Material Information View PDF
2022-02-11 Board Meeting View
2021-12-31 Material Information View
2021-12-29 Resolutions Passed in Annual General Meeting View PDF
2021-11-25 Credit of Final Cash Dividend View
2021-11-22 Material Information View
2021-11-18 Credit of Bonus Share Certificates View PDF
2021-11-01 Transmission of Quarterly Report for the period September 30, 2021 View PDF
2021-10-29 Financial Results for the first quarter ended September 30, 2021 View PDF
2021-10-22 Board Meeting View
2021-10-07 Transmission of Annual Report for the year ended June 30, 2021 View PDF
2021-10-07 Notice of Annual General Meeting View PDF
2021-09-30 Financial Results for the year ended June 30, 2021 View PDF
2021-09-23 Board Meeting View
2021-09-16 Material Information View PDF
2021-09-13 Decisions of Baord Meeting View PDF
2021-08-31 Board Meeting View
2021-08-13 Decisions of the Board Meeting View PDF
2021-08-06 Board Meeting View
2021-08-06 Board Meeting REVOKED View
2021-08-06 Board Meeting View
2021-08-06 Change of Director View
2021-07-27 Change of Director View
2021-07-14 Material Information View PDF

About Company

Citi Pharma Limited incorporated as a private limited company in Pakistan under the repealed Companies Ordinance, 1984 on October 08, 2012. The principal activity of the company is manufacturing and sale of pharmaceuticals, medical chemicals and botanical products.

Address
3-KM, Head Balloki Road, Bhai Pheru, Distt Kasur
Website
www.citipharma.com.pk
Key People
Mr. Rizwan Ahmad CEO
Mr. Nadeem Amjad Chairman
Mr. Muhammad Riaz Company Secretary

Page description

CPHL (Citi Pharma Ltd.) listed in PSX,ACI,ALLSHR,KMIALLSHR. CPHL Share Price / Stock Price is 28.90 PKR. You can also check; Share Price History, CPHLPayouts, Annoucements, Snapshot, Company details, Fundamentals, Technicals and much more.

CPHL Share Price CPHL Stock Price Citi Pharma Ltd. psx stock kse100 stock CPHL Stock Price ACI ALLSHR KMIALLSHR Share price History CPHL Payouts Annoucements Snapshot CPHL Address CPHL CEO Book Value Price/Book Ratio Dividend Yield Earning Per Share Net Profit Margin Gross Profit Margin Price to Sales Ratio Long Term Debt to Equity Interest Cover (Times) Equity to Assets (%) Current Ratio (Times) Cash Payout Ratio Technical Indicators Moving Averages CPHL Chairperson CPHL Secretary CPHL Website About CPHL

My Watchlist

Not logged in, please login to view watchlist!

Today's Market Performers KSE100

Change
loading

Financial literacy is your key to success and a promise of a secure future in turbulent times. We offer you the right education and resources you need to achieve your financial dreams. Sarmaaya is a trusted source of research and information about Forex, Mutual Funds, and Stocks. Our widgets, tools and calculators aid in identifying potential investment opportunities and valuable insights that can help achieve your short and long-term financial goals.

© 2024 SARMAAYA.PK

Sarmaaya Financials Private Limited is a Pakistan Stock Exchange (PSX) authorized data redistributor. Sarmaaya & CS Solutions (Pvt.) Limited (CS) do not guarantee the timeliness, accurateness, or completeness of any data or information on the website. Sarmaaya & CS makes no warranties, express or implied, as to Sarmaaya & CS or any data or values relating thereto or results to be obtained therefrom, and expressly disclaims all warranties of merchantability and fitness for a particular purpose with respect thereto. To the maximum extent allowed by law, Sarmaaya & CS, its licensors, and their respective employees, contractors, agents, suppliers and vendors shall have no liability or responsibility whatsoever for any injury or damages – whether direct, indirect, consequential, incidental, punitive or otherwise – arising in connection with Sarmaaya & CS or any data or values relating thereto – whether arising from their negligence or otherwise. Nothing in the website shall constitute or be construed as an offering of financial instruments or as investment advice or investment recommendations (i.e., recommendations as to whether or not to “buy”, “sell”, “hold”, or to enter or not to enter into any other transaction involving any specific interest or interests) by Sarmaaya & CS or a recommendation as to an investment or other strategy by Sarmaaya & CS. Data and other information available via the website should not be considered as information sufficient upon which to base an investment decision.